3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
7
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Hodgkin Disease
1
GATA2 Deficiency
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
Magnetic Resonance Spectroscopy
28
enzalutamide
27
Specimen Handling
21
apalutamide
18
Androgen Antagonists
16
Prednisone
15
Abiraterone Acetate
15
Radiosurgery
13
abiraterone
11
Radiotherapy
10
Docetaxel
10
Biopsy
9
darolutamide
8
Pluvicto
8
Nivolumab
8
niraparib
6
cabazitaxel
6
Surveys and Questionnaires
6
Radiation
6
Lutetium-177
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
gallium 68 PSMA-11
5
bicalutamide
5
Radiotherapy, Intensity-Modulated
5
Lutetium
5
Gonadotropin-Releasing Hormone
5
radium Ra 223 dichloride
4
pembrolizumab
4
luprolide acetate gel depot
4
cabozantinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
decitabine and cedazuridine drug combination
×
30 days
×
Clear all
No trials found.